Clinical Trials Logo

Very Low Birth Weight clinical trials

View clinical trials related to Very Low Birth Weight.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02447250 Completed - Clinical trials for Bronchopulmonary Dysplasia

Preterm Infant Inhaled Albuterol Dosing

Start date: October 24, 2013
Phase: Phase 4
Study type: Interventional

The purpose of this study is to help determine the best dose of inhaled albuterol sulfate in premature babies at risk of developing bronchopulmonary dysplasia (BPD). BPD is the chronic lung disease of prematurity and is associated with increased morbidity and mortality, longer hospital stays, and increased healthcare utilization. Albuterol is an inhaled medication frequently used in premature infants with chronic lung disease and in people with asthma. It is believed to be safe, but the optimal dose for infants is not clear. The investigators hypothesize that albuterol may help a subset of premature infants with lung disease, but they need to determine the best dose prior to doing research about how effective it is for chronic lung disease/BPD. Response to each of three doses of albuterol will be measure using pulmonary function tests.

NCT ID: NCT01817062 Completed - Clinical trials for Very Low Birth Weight

Neonates With Very Low Birth Weight and Surgery Therapy of Acute Abdomen

NeoNec
Start date: January 2001
Phase: N/A
Study type: Observational

Objective: Due to high mortality rates the capillary leakage and the acute abdomen are important risk factors of the probability of survival. The aim of an optimal therapy of the acute abdomen within the neonatal period is beside the cure of the underlying disease the prophylaxis of capillary leakage with the help of optimised intra- and postoperative volume therapy. Question: Do the neonates with very low birth weight and a surgery therapy of acute abdomen benefit from early increase of the haemoglobin/haematocrit by optimised volume therapy with crystalloid and colloidal volume as prophylaxis of the capillary leakage?

NCT ID: NCT00593684 Completed - Prematurity Clinical Trials

The Safety Evaluation of Silver Alginate (Algidex™) Dressing in Very Low Birth Weight (VLBW) Infants

Start date: April 2006
Phase: N/A
Study type: Interventional

The purpose of this study is to test the safety of silver alginate (Algidex™) dressing in VLBW infants in preparation for a large efficacy trial.